Knight Therapeutics Inc. (GUD.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 602.38M |
| Enterprise Value | 603.84M |
| P/E Ratio | 181.48 |
| PEG Ratio | -1.29 |
| Price/Sales Ratio | 1.79 |
| Price/Book Ratio | 1.16 |
| Enterprise/Revenue | 1.72 |
| Enterprise/EBITDA | 13.44 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.03 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 450.09M |
| Revenue/Share | 5.18 |
| Gross Profit | 150.74M |
| EBITDA | 54.37M |
| Net Income | -5.37M |
| Diluted EPS | -0.05 |
Balance Sheet
| Total Cash | 127.29M |
| Total Cash/Share | 1.29 |
| Total Debt | 69.78M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 2.32 |
| Book Value Per Share | 8 |
Price History
| 52-Week Change | 60.24 |
| 52-Week High | 9.59 |
| 52-Week Low | 5.66 |
| Moving Average 50 Days | 8.24 |
| Moving Average 200 Days | 6.68 |
Statistics
| Average Volume | 88,598 |
| Shares Outstanding | 98.18M |
| % Held by Institutions | 0.13 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
